Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-26

Clinical Trial Update: LUMENS-1 EU EFS CIP [NA]

View source ↗

Summary

The LUMENS-1 EU EFS CIP trial sponsored by LuSeed Vascular LTD is currently recruiting patients for cerebral aneurysm-related conditions, including unruptured i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: LuSeed Vascular LTD. | Conditions: Aneurysm Cerebral, Bifurcation | NA | Status: RECRUITING